Smad3 is a downstream transcription factor in the TGFβ signalling pathway; mutations in SMAD3 can cause an aneurysms-osteoarthritis syndrome with features of craniofacial and skeletal abnormalities50. Here, SMAD3 is linked to aneurysm.